Yongik Lee

Yongik Lee

Astellas Pharma Inc - Tokyo / Japan
Medical and Health Sciences / Pharmacology
AD Scientific Index ID: 4407760
アステラス製薬株式会社
person_outline Yongik Lee's MOST POPULAR ARTICLES
1-) Polycomb-and methylation-independent roles of EZH2 as a transcription activatorJ Kim, Y Lee, X Lu, B Song, KW Fong, Q Cao, JD Licht, JC Zhao, J YuCell reports 25 (10), 2808-2820. e4, 20181672018
2-) Targeting lonidamine to mitochondria mitigates lung tumorigenesis and brain metastasisG Cheng, Q Zhang, J Pan, Y Lee, O Ouari, M Hardy, M Zielonka, ...Nature communications 10 (1), 1-14, 20191122019
3-) Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progressionB Song, SH Park, JC Zhao, K Fong, S Li, Y Lee, YA Yang, S Sridhar, X Lu, ...The Journal of clinical investigation 129 (2), 569-582, 2019852019
4-) Inhibition of IGF1R signaling abrogates resistance to afatinib (BIBW2992) in EGFR T790M mutant lung cancer cellsY Lee, Y Wang, M James, JH Jeong, M YouMolecular carcinogenesis 55 (5), 991-1001, 2016712016
5-) Posttranslational regulation of FOXA1 by Polycomb and BUB3/USP7 deubiquitin complex in prostate cancerSH Park, K Fong, J Kim, F Wang, X Lu, Y Lee, LT Brea, K Wadosky, C Guo, ...Science advances 7 (15), eabe2261, 2021612021